These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32309634)

  • 1. Nitric oxide-releasing alginates as mucolytic agents.
    Ahonen MJR; Hill DB; Schoenfisch MH
    ACS Biomater Sci Eng; 2019 Jul; 5(7):3409-3418. PubMed ID: 32309634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models.
    Rouillard KR; Hill DB; Schoenfisch MH
    J Cyst Fibros; 2020 Nov; 19(6):1004-1010. PubMed ID: 32205069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiofilm Efficacy of Nitric Oxide-Releasing Alginates against Cystic Fibrosis Bacterial Pathogens.
    Ahonen MJR; Dorrier JM; Schoenfisch MH
    ACS Infect Dis; 2019 Aug; 5(8):1327-1335. PubMed ID: 31136714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Nitric Oxide-Releasing Chitosan Oligosaccharides on Mucus Viscoelasticity.
    Reighard KP; Ehre C; Rushton ZL; Ahonen MJR; Hill DB; Schoenfisch MH
    ACS Biomater Sci Eng; 2017; 3(6):1017-1026. PubMed ID: 30320206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric Oxide-Releasing Alginates.
    Ahonen MJR; Suchyta DJ; Zhu H; Schoenfisch MH
    Biomacromolecules; 2018 Apr; 19(4):1189-1197. PubMed ID: 29551064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable microparticles designed to efficiently reach and act on cystic fibrosis mucus barrier.
    Cristallini C; Barbani N; Ventrelli L; Summa C; Filippi S; Capelôa T; Vitale E; Albera C; Messore B; Giachino C
    Mater Sci Eng C Mater Biol Appl; 2019 Feb; 95():19-28. PubMed ID: 30573241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucolytic treatment with N-acetylcysteine L-lysinate metered dose inhaler in dogs: airway epithelial function changes.
    Tomkiewicz RP; App EM; Coffiner M; Fossion J; Maes P; King M
    Eur Respir J; 1994 Jan; 7(1):81-7. PubMed ID: 8143836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus.
    Martin R; Litt M; Marriott C
    Am Rev Respir Dis; 1980 Mar; 121(3):495-500. PubMed ID: 6968166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mucolytic agents on the rheological properties of tracheal mucus.
    Khan MA; Wolf DP; Litt M
    Biochim Biophys Acta; 1976 Sep; 444(2):369-73. PubMed ID: 971413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of N-acetyl-L-cysteine on the viscosity of ileal neobladder mucus.
    Schrier BP; Lichtendonk WJ; Witjes JA
    World J Urol; 2002 May; 20(1):64-7. PubMed ID: 12088194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative mucolytic studies on dithiothreitol, N-acetyl-cysteine and L-cysteine on human respiratory mucus in vitro and their effects on the rate of flow of mucus in the exposed trachea of the rat on topical application.
    Lightowler JE; Lightowler NM
    Arch Int Pharmacodyn Ther; 1971 Jan; 189(1):53-8. PubMed ID: 5130152
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment.
    Braga PC; Bossi R; Allegra L
    Int J Clin Pharmacol Res; 1984; 4(2):121-7. PubMed ID: 6469438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro rheological assessment of mucolytic activity induced by seaprose.
    Braga PC; Rampoldi C; Ornaghi A; Caminiti G; Beghi G; Allegra L
    Pharmacol Res; 1990; 22(5):611-7. PubMed ID: 2277801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro mucolytic effect of xylitol and dornase alfa on chronic rhinosinusitis mucus.
    Hardcastle T; Jain R; Radcliff F; Waldvogel-Thurlow S; Zoing M; Biswas K; Douglas R
    Int Forum Allergy Rhinol; 2017 Sep; 7(9):889-896. PubMed ID: 28658521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiolated polyglycerol sulfate as potential mucolytic for muco-obstructive lung diseases.
    Arenhoevel J; Kuppe A; Addante A; Wei LF; Boback N; Butnarasu C; Zhong Y; Wong C; Graeber SY; Duerr J; Gradzielski M; Lauster D; Mall MA; Haag R
    Biomater Sci; 2024 Aug; 12(17):4376-4385. PubMed ID: 39028033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viscoelastic properties of bronchial mucus after respiratory physiotherapy in subjects with bronchiectasis.
    Ramos EM; Ramos D; Moreira GL; Macchione M; Guimarães ET; Rodrigues FM; de Souza AA; Saldiva PH; Jardim JR
    Respir Care; 2015 May; 60(5):724-30. PubMed ID: 25650436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation increases mucin polymer cross-links to stiffen airway mucus gels.
    Yuan S; Hollinger M; Lachowicz-Scroggins ME; Kerr SC; Dunican EM; Daniel BM; Ghosh S; Erzurum SC; Willard B; Hazen SL; Huang X; Carrington SD; Oscarson S; Fahy JV
    Sci Transl Med; 2015 Feb; 7(276):276ra27. PubMed ID: 25717100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model systems for the evaluation of mucolytic drugs: acetylcysteine and S-carboxymethylcysteine.
    Livingstone CR; Andrews MA; Jenkins SM; Marriott C
    J Pharm Pharmacol; 1990 Feb; 42(2):73-8. PubMed ID: 1972405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of purified mucus glycoprotein gels in the assessment of mucolytic activity.
    Marriott C; Brown DT; Beeson MF
    Biorheology; 1983; 20(1):71-9. PubMed ID: 6871427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus and Escherichia coli from bovine mastitis.
    Cardozo VF; Lancheros CA; Narciso AM; Valereto EC; Kobayashi RK; Seabra AB; Nakazato G
    Int J Pharm; 2014 Oct; 473(1-2):20-9. PubMed ID: 24979535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.